What's Happening?
Congress is actively considering increased funding and policy changes for animal health management and disease prevention programs under the U.S. Department of Agriculture (USDA), specifically through the Animal Health Protection Act (AHPA) and the Animal and Plant
Health Inspection Service (APHIS). In fiscal year 2026, APHIS managed programs totaling approximately $527 million to execute AHPA authorities, covering aquatic, avian, cattle, equine, and swine health. Historically, animal health provisions have been integrated into the miscellaneous title of the farm bill. The Agriculture Improvement Act of 2018 (2018 farm bill) established two new animal health programs, boosted funding for existing disease prevention and management activities, and authorized USDA to develop veterinary training programs at colleges of veterinary medicine. As the next farm bill is being drafted, lawmakers are focusing on federal support to mitigate and manage the risks of animal diseases and pests in domestic livestock. Recent legislative actions, such as P.L. 119-21, have already increased mandatory funding for key programs like the National Animal Disease Preparedness and Response Program (NADPRP), the National Animal Vaccine and Veterinary Countermeasures Bank (NAVVCB), and the National Animal Health Laboratory Network (NAHLN) through FY2031.
Why It's Important?
The proposed enhancements to USDA animal health programs are crucial for several reasons, impacting the U.S. economy, public health, and food security. Animal agriculture is projected to contribute $274 billion to U.S. farm and ranch production in 2026, representing 53% of the total value of U.S. agricultural products. The World Organization for Animal Health reports that about 60% of known human infectious diseases originate in animals, and 76% of emerging diseases have an animal origin, underscoring the public health implications of animal health. Diseases like foot-and-mouth disease (FMD), African swine fever (ASF), and highly pathogenic avian influenza (HPAI) can lead to significant productivity losses, are costly to control, and can disrupt both domestic food supply chains and international trade. Strengthening these programs protects the economic viability of the livestock industry, safeguards public health by preventing zoonotic disease transmission, and ensures the stability of the nation's food supply. The increased funding and expanded scope, including provisions for animal disease traceability and regional export ban agreements, aim to minimize the economic fallout from outbreaks and maintain U.S. competitiveness in global agricultural markets.
What's Next?
As Congress moves forward with authorizing the next farm bill, several key developments are anticipated. Both the House-passed Farm, Food, and National Security Act of 2026 (H.R. 7567) and the Senate's discussion draft, the Agriculture Act of 2026, include provisions to expand the scope of animal health programs. The Senate bill, for instance, proposes increasing discretionary appropriations for NAHLN from $30 million to $45 million and broadening NAVVCB to include countermeasures for livestock pests, such as supporting domestic production of sterile flies. Both bills also aim to expand NADPRP to improve animal disease traceability and extend the authorization of appropriations for the three animal health programs until FY2031. Additionally, both legislative proposals would authorize USDA to preemptively negotiate regional export ban agreements for known animal disease threats. This measure, known as regionalization, would allow for the continuation of exports from disease-free zones within the U.S., potentially reducing or eliminating nation-level trade restrictions during outbreaks. These legislative efforts indicate a concerted push to fortify the nation's defenses against animal diseases and their broader impacts.
Beyond the Headlines
Beyond the immediate legislative and financial implications, the ongoing congressional focus on animal health programs highlights deeper shifts in agricultural policy and public health strategy. The emphasis on animal disease traceability reflects a growing recognition of the need for more sophisticated and rapid response mechanisms to outbreaks. While supported by many in the livestock industry, traceability measures also raise concerns about regulatory costs and the confidentiality of business data, pointing to a delicate balance between public good and individual enterprise. The push for regionalization in trade agreements signifies a proactive approach to international commerce, aiming to mitigate the economic damage from disease outbreaks by maintaining export capabilities from unaffected areas. This strategy requires robust testing, biosecurity protocols, and strict adherence to disease-free status, potentially setting new standards for global agricultural trade. Furthermore, the continued investment in veterinary training programs underscores a long-term commitment to building a skilled workforce capable of addressing complex animal health challenges, acknowledging the critical role of veterinary medicine in national security and economic stability.
